Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Invested Capital (2016 - 2025)

Historic Invested Capital for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $133.0 million.

  • Tandem Diabetes Care's Invested Capital fell 5222.5% to $133.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.0 million, marking a year-over-year decrease of 5222.5%. This contributed to the annual value of $303.8 million for FY2024, which is 314.51% down from last year.
  • Per Tandem Diabetes Care's latest filing, its Invested Capital stood at $133.0 million for Q3 2025, which was down 5222.5% from $133.3 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Invested Capital registered a high of $449.6 million during Q2 2022, and its lowest value of $133.0 million during Q3 2025.
  • In the last 5 years, Tandem Diabetes Care's Invested Capital had a median value of $314.0 million in 2023 and averaged $320.4 million.
  • Per our database at Business Quant, Tandem Diabetes Care's Invested Capital skyrocketed by 5127.91% in 2021 and then plummeted by 5222.5% in 2025.
  • Tandem Diabetes Care's Invested Capital (Quarter) stood at $433.1 million in 2021, then rose by 1.58% to $439.9 million in 2022, then dropped by 28.71% to $313.6 million in 2023, then fell by 3.15% to $303.8 million in 2024, then plummeted by 56.23% to $133.0 million in 2025.
  • Its last three reported values are $133.0 million in Q3 2025, $133.3 million for Q2 2025, and $196.0 million during Q1 2025.